DalsnaFinance

MannKind completes patient enrollment in nintedanib DPI trials

Markets Investing.com By Investing.com 03 Jun 2026 10:16 1 min read
MannKind completes patient enrollment in nintedanib DPI trials

MannKind completes patient enrollment in nintedanib DPI trials

MannKind completes patient enrollment in nintedanib DPI trials

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.